— Know what they know.
Not Investment Advice
Also trades as: CDTTW (NASDAQ) · $vol 0M

CDT NASDAQ

CDT Equity Inc.
1W: -50.5% 1M: +8.8% 3M: -78.2% YTD: -31.2% 1Y: -82.2% 3Y: -100.0%
$0.99
-0.26 (-20.80%)
 
Weekly Expected Move ±1052.8%
$-20 $-9 $1 $11 $22
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $763021 mcap · 343924 float · 34.74% daily turnover · Short 44% of daily vol
0.00
Neutral
0 bullish 0 neutral 0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish 0 neutral 0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (33)
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
Bullish GlobeNewsWire-FDA · 4d ago · 0.90
CDT Equity announces 1-for-25 reverse stock split
Bearish SeekingAlpha · 1w ago · -0.90
CDT appoints co-founder James Bligh as CEO
SeekingAlpha · 4w ago · 0.00
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
Bullish GlobeNewsWire-FDA · 5w ago · 0.90
CDT Equity enters SAFE investment with Pep'd to expand U.S. peptide market footprint
Bullish SeekingAlpha · 5w ago · 0.90
CDT Equity announces 1-for-10 reverse stock split
Bearish SeekingAlpha · 11w ago · -0.90
CDT Equity Stock Gets A Boost On SarborgQ Development News
Bullish Benzinga-Movers · 15w ago · 0.90
12 Health Care Stocks Moving In Thursday's Intraday Session
Bullish Benzinga-Movers · 15w ago · 0.90
12 Health Care Stocks Moving In Friday's Intraday Session
Bullish Benzinga-Movers · 18w ago · 0.90
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
Bearish GlobeNewsWire-Earnings · 18w ago · -0.90
CDT Announces Canadian Patent for AZD5904 in Male Infertility
GlobeNewsWire-FDA · 18w ago · 0.00
12 Health Care Stocks Moving In Monday's After-Market Session
Bullish Benzinga-Movers · 19w ago · 0.90
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
Bullish Benzinga-News · 21w ago · 0.90
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
Bullish Benzinga-News · 21w ago · 0.90
12 Health Care Stocks Moving In Friday's After-Market Session
Bullish Benzinga-Movers · 23w ago · 0.90
What's Going On With CDT Equity Shares On Monday?
Bullish Benzinga-Movers · 24w ago · 0.90
12 Health Care Stocks Moving In Friday's Intraday Session
Bullish Benzinga-Movers · 25w ago · 0.90
12 Health Care Stocks Moving In Thursday's After-Market Session
Bullish Benzinga-Movers · 26w ago · 0.90
12 Health Care Stocks Moving In Thursday's Intraday Session
Bullish Benzinga-Movers · 26w ago · 0.90
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Bullish Benzinga-Movers · 26w ago · 0.90
12 Health Care Stocks Moving In Wednesday's After-Market Session
Bullish Benzinga-Movers · 26w ago · 0.90
Why Virgin Galactic Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Bullish Benzinga-Movers · 26w ago · 0.90
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
Bullish Benzinga-News · 27w ago · 0.90
CDT Equity announces reverse stock split
Bearish SeekingAlpha · 27w ago · -0.90
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
GlobeNewsWire-FDA · 27w ago · 0.00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Bullish Benzinga-Movers · 27w ago · 0.90
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
Bullish GlobeNewsWire-FDA · 29w ago · 0.90
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
Benzinga-News · 30w ago · 0.00
CDT Positions for Transformational Growth
Bullish Benzinga-News · 30w ago · 0.90
CDT Positions for Transformational Growth
Bullish GlobeNewsWire-MandA · 30w ago · 0.90
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
GlobeNewsWire · 31w ago · 0.00
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
Bullish GlobeNewsWire · 32w ago · 0.90
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy
GlobeNewsWire · 39w ago · 0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms